Document is current
Any future updates will be listed below
-
Authors
Wirth, Wolfgang https://orcid.org/0000-0002-2297-8283
Maschek, Susanne
Wisser, Anna
Eder, Jana
Baumgartner, Christian F.
Chaudhari, Akshay
Berenbaum, Francis
Eckstein, Felix
,
-
Funding
Funding for this research was provided by:
Eurostars (E! 114932)
National Institutes of Health (N01AR22258)
National Institutes of Health (N01AR22259)
National Institutes of Health (N01AR22260)
National Institutes of Health (N01AR22261)
National Institutes of Health (N01AR22262)
Bundesministerium für Bildung und Forschung (01EC1408D)
Paracelsus Medical University
- License Information
-
More Information
Article History
Received: 3 July 2024
Revised: 26 August 2024
Accepted: 27 August 2024
First Online: 4 September 2024
Declarations
:
: Wolfgang Wirth and Susanne Maschek: employees and shareholders of Chondrometrics GmbH, a company that provides image analysis services and that received funding from multiple sources, including public bodies and the pharmaceutical industry (detailed list upon request). Anna Wisser: Employee of Chondrometrics GmbH. Jana Eder: employee of Siemens AG Österreich. Christian Baumgartner: none. Akshay Chaudhari: shareholder of Subtle Medical, Brain Key, and LVIS Corp; received personal fees from Subtle Medical and Patient Square Capital. Francis Berenbaum: consulting or speaker fees from 4P Pharma, Grunenthal, GSK, Eli Lilly, Heel, AstraZeneca, Diffusion Rx, Nordic Bioscience, Novartis, Pfizer, Servier, Zoetis. Shareholder of 4Moving Biotech. Felix Eckstein: CEO and shareholder of Chondrometrics GmbH. He provided consulting services to Merck KGA, Kolon Tissuegene (KTG), Galapagos, Novartis, 4P Pharma, and Formation Bio.
